pharmaphorum Podcast

A clearer harmony and attractiveness for EU Clinical Trials Regulation

For the latest episode of the pharmaphorum podcast, web editor Nicole Raleigh sat down with Chris Bamford, director of clinical trial regulatory management at IQVIA, and Shirley Rutter, associate director and strategic quality lead of global quality management at IQVIA Biotech

Making connections and getting noticed as a biotech start-up

On today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director of Business Development; Mike Murray, head of Murray International Partners Ltd; and Mairi Dillon, Kadans' Ecosystem Manager for UK & Ireland.  

Getting down to the nitty gritty of actively creating healthier societies

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Stuart Cooper, CEO of Adelphi Group, about Anthropy – a yearly event that aims to spark innovation and foster fresh thinking among diverse leaders – and about creating healthier societies, about biopharma’s role in that, including implementation of preventative methods in ameliorating global health.

How manufacturing keeps pace with innovation in cell and gene therapy

On today’s podcast, host Jonah Comstock is joined by Arturo Araya, is EVP of Commercialisation at Cellares, a company that is attempting to create a new kind of contract manufacturing organisation for the rapidly crystalizing world of cell and gene therapy.  

Fixing the inequity of drug access outside of the US

In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorluhar, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial resistance (AMR) and what the biotech industry should be focussing on in order to address this critical issue outside of the West.

Key themes from JP Morgan

Editor in Chief Jonah Comstock is back from San Francisco where he attended the annual JP Morgan Healthcare Conference. On today’s episode, guest host Eloise McLennan interviews Jonah about what he saw and heard at the show.  

Prediction is very difficult, especially if it’s about the future

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.

Promoting value-added medicines and renovating old medicines smartly

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

Digitisation of drug R&D: Avoiding new for novelty’s sake

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

The problems of animal research for human medicine and the alternatives

In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust, a charity aiming to improve the safety of medicines by facilitating a transition to human biology-based drug development and testing.